Annual Working Capital
$50.92 M
-$4.94 M-8.84%
01 June 2022
Summary:
Pluristem Therapeutics annual working capital is currently $50.92 million, with the most recent change of -$4.94 million (-8.84%) on 01 June 2022. During the last 3 years, it has fallen by -$4.94 million (-8.84%).PSTI Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$44.70 M
-$6.21 M-12.20%
01 September 2022
Summary:
Pluristem Therapeutics quarterly working capital is currently $44.70 million, with the most recent change of -$6.21 million (-12.20%) on 01 September 2022.PSTI Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -8.8% | -14.8% |
| 5 y5 years | +179.6% | +228.0% |
PSTI Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -8.8% | -31.0% |
Pluristem Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $44.70 M(-12.2%) |
| June 2022 | $50.92 M(-8.8%) | $50.92 M(-9.9%) |
| Mar 2022 | - | $56.49 M(+11.7%) |
| Dec 2021 | - | $50.56 M(-3.6%) |
| Sept 2021 | - | $52.46 M(-6.1%) |
| June 2021 | $55.85 M(+38.0%) | $55.85 M(+40.0%) |
| Mar 2021 | - | $39.90 M(+13.2%) |
| Dec 2020 | - | $35.25 M(+2.6%) |
| Sept 2020 | - | $34.35 M(-15.1%) |
| June 2020 | $40.47 M(+122.2%) | $40.47 M(+281.1%) |
| Mar 2020 | - | $10.62 M(-13.2%) |
| Dec 2019 | - | $12.24 M(-10.2%) |
| Sept 2019 | - | $13.63 M(-25.2%) |
| June 2019 | $18.21 M(-22.5%) | $18.21 M(+268.0%) |
| Mar 2019 | - | $4.95 M(-55.5%) |
| Dec 2018 | - | $11.12 M(-34.8%) |
| Sept 2018 | - | $17.05 M(-27.4%) |
| June 2018 | $23.49 M(-0.5%) | $23.49 M(-15.8%) |
| Mar 2018 | - | $27.90 M(-10.8%) |
| Dec 2017 | - | $31.28 M(+73.1%) |
| Sept 2017 | - | $18.07 M(-23.4%) |
| June 2017 | $23.60 M(-20.9%) | $23.60 M(-17.1%) |
| Mar 2017 | - | $28.47 M(+62.0%) |
| Dec 2016 | - | $17.58 M(-29.5%) |
| Sept 2016 | - | $24.94 M(-16.4%) |
| June 2016 | $29.82 M(-41.2%) | $29.82 M(-13.1%) |
| Mar 2016 | - | $34.32 M(-14.6%) |
| Dec 2015 | - | $40.17 M(-9.9%) |
| Sept 2015 | - | $44.57 M(-12.1%) |
| June 2015 | $50.69 M(-7.2%) | $50.69 M(+31.1%) |
| Mar 2015 | - | $38.67 M(-7.8%) |
| Dec 2014 | - | $41.96 M(-9.4%) |
| Sept 2014 | - | $46.31 M(-15.2%) |
| June 2014 | $54.59 M(+11.0%) | $54.59 M(-6.3%) |
| Mar 2014 | - | $58.27 M(+10.3%) |
| Dec 2013 | - | $52.82 M(+13.0%) |
| Sept 2013 | - | $46.74 M(-4.9%) |
| June 2013 | $49.16 M(+50.5%) | $49.16 M(-11.2%) |
| Mar 2013 | - | $55.34 M(-8.0%) |
| Dec 2012 | - | $60.15 M(-7.1%) |
| Sept 2012 | - | $64.75 M(+98.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | $32.67 M(-20.9%) | $32.67 M(-10.7%) |
| Mar 2012 | - | $36.60 M(-5.8%) |
| Dec 2011 | - | $38.87 M(-5.9%) |
| Sept 2011 | - | $41.32 M(+0.1%) |
| June 2011 | $41.28 M(+1676.2%) | $41.28 M(-5.6%) |
| Mar 2011 | - | $43.71 M(+978.8%) |
| Dec 2010 | - | $4.05 M(+358.9%) |
| Sept 2010 | - | $883.00 K(-62.0%) |
| June 2010 | $2.32 M(+10.9%) | $2.32 M(+83.4%) |
| Mar 2010 | - | $1.27 M(-57.8%) |
| Dec 2009 | - | $3.00 M(+75.6%) |
| Sept 2009 | - | $1.71 M(-18.5%) |
| June 2009 | $2.10 M(+102.4%) | $2.10 M(+21.1%) |
| Mar 2009 | - | $1.73 M(-15.3%) |
| Dec 2008 | - | $2.04 M(+13.0%) |
| Sept 2008 | - | $1.81 M(+74.7%) |
| June 2008 | $1.03 M(-80.5%) | $1.03 M(-64.0%) |
| Mar 2008 | - | $2.88 M(-33.0%) |
| Dec 2007 | - | $4.29 M(-11.6%) |
| Sept 2007 | - | $4.86 M(-8.7%) |
| June 2007 | $5.32 M(+195.1%) | $5.32 M(+139.2%) |
| Mar 2007 | - | $2.22 M(+690.9%) |
| Dec 2006 | - | $281.20 K(-77.3%) |
| Sept 2006 | - | $1.24 M(-31.4%) |
| June 2006 | $1.80 M(+9.4%) | $1.80 M(-8565.3%) |
| Mar 2006 | - | -$21.30 K(-104.1%) |
| Dec 2005 | - | $518.50 K(-57.0%) |
| Sept 2005 | - | $1.20 M(-26.9%) |
| June 2005 | $1.65 M(+371.4%) | $1.65 M(-22.6%) |
| Mar 2005 | - | $2.13 M(-1908.8%) |
| Dec 2004 | - | -$117.70 K(+66.5%) |
| Sept 2004 | - | -$70.70 K(-120.2%) |
| June 2004 | $349.50 K(+33.6%) | $349.50 K(-64.0%) |
| Mar 2004 | - | $971.20 K(-609.3%) |
| Dec 2003 | - | -$190.70 K(-174.1%) |
| Sept 2003 | - | $257.30 K(-1.6%) |
| June 2003 | $261.60 K(-446.9%) | $261.60 K(-1125.9%) |
| Mar 2003 | - | -$25.50 K(+37.8%) |
| Dec 2002 | - | -$18.50 K(+77.9%) |
| Sept 2002 | - | -$10.40 K(-86.2%) |
| June 2002 | -$75.40 K | -$75.40 K |
FAQ
- What is Pluristem Therapeutics annual working capital?
- What is the all time high annual working capital for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Pluristem Therapeutics?
What is Pluristem Therapeutics annual working capital?
The current annual working capital of PSTI is $50.92 M
What is the all time high annual working capital for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual working capital is $55.85 M
What is Pluristem Therapeutics quarterly working capital?
The current quarterly working capital of PSTI is $44.70 M
What is the all time high quarterly working capital for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly working capital is $64.75 M